Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jishan Quan"'
Autor:
Wen‐Bo Xu, Yu‐Qing Meng, Jingxin Sun, Yu‐Xuan Yang, Wan‐Xin Li, Man‐Yu Wang, Ming‐Guan Piao, Siqi Li, Jishan Quan, Cheng‐Hua Jin
Publikováno v:
Chemistry & Biodiversity. 20
Publikováno v:
Open Life Sciences. 17:952-959
This study aims to synthesize a magnetic resonance imaging (MRI) contrast agent that can specifically target the asialoglycoprotein receptor of liver cancer cells and evaluate its ability as a targeted MRI contrast agent. Lactobionic acid (LA) and po
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:2070-2075
Transforming growth factor (TGF-β), a key mediator of tumor growth and metastasis, has been recognized as an important cancer drug target. A series of benzo[c][1,2,5]thiadiazol-5-yl imidazoles (14a–g) and thieno[3,2-c]-pyridin-2-yl imidazoles (20a
Autor:
Bryant C. Yung, Hong Li, Young Bok Lee, Deog Joong Kim, Robert J. Lee, Jishan Quan, Yang Liu, Xinwei Cheng, Mengzi Zhang, Chang-Ho Ahn
Publikováno v:
Molecular Pharmaceutics. 13:2555-2562
Lipid-albumin nanoparticles (LAN) were synthesized for delivery of RX-0047, an antisense oligonucleotide (ASO) against the hypoxia inducible factor-1 alpha (HIF-1α) to solid tumor. These lipid nanoparticles (LNs) incorporated a human serum albumin-p
Autor:
Mengzi Zhang, Jiuxia Pang, John C. Byrd, Kenneth K. Chan, Natarajan Muthusamy, Young Ah Cho, Songlin Xu, Guido Marcucci, Bryant C. Yung, Hong Li, Robert J. Lee, L. James Lee, Jishan Quan, Shujun Liu, Chenguang Zhou
CD33-targeted lipid nanoparticles (aCD33LNs) were synthesized for delivery of GTI-2040, an antisense oligonucleotide (ASO) against the R2 subunit of ribonucleotide reductase, to acute myelogenous leukemia (AML). These LNs incorporated a deoxycholate-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba5b0d33d60c754ed43bb6a0b288ae1b
https://europepmc.org/articles/PMC4962870/
https://europepmc.org/articles/PMC4962870/